Protocol No
ADP-0055-001-MAGE-A4-SURPASS
Phase
I
Summary
This is a study to find out more about the side effects (problems and symptoms) of a new drug; ADP-A2M4CD8 and what doses of ADP-A2M4CD8 are safe for people to take for MAGE- A4 Positive Tumors (urothelial cancer, melanoma, head and neck cancer, ovarian cancer, non- small cell lung cancer, esophageal cancer, esophagogastric junction cancer, gastric cancer, synovial sarcoma, and myxoid/round cell liposarcoma cancer cell).
Description
ADP-A2M4CD8 in HLA-A2+ Subjects with MAGE-A4 Positive Tumors
Participating Institutions
Froedtert Hospital
Status
OPEN TO ACCRUAL
Categories
Cancer,
Colorectal,
Skin Cancers,
Thoracic Cancers,
Sarcoma,
Prostate and Urologic Cancers,
Head and Neck Cancers,
Gynecologic Cancers,
Gastrointestinal Cancers,
Other Respiratory,
Lung,
Esophagus,
Other Skin,
Melanoma, Skin,
Other Urologic,
Bladder,
Lip, Oral Cavity and Pharynx,
Larynx,
Other Gynecologic,
Ovary,
Cervix,
Other Gastrointestinal,
Stomach,
Pancreas/Liver,
Esophagus
ClinicalTrials.gov